| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.0048 | 1 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |